Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Memorial Sloan Kettering Cancer Center
Headquarters: New York, NY, United States of America
Website: http://mskcc.org/
Year Founded: 1884
Status: Non-biopharma
Biopharma related deals can be found by searching the organization's name in the Deals Module.
BioCentury | Apr 1, 2025
Distillery Therapeutics
Engineered IL33 protein for pancreatic cancer antitumor immunity
BioCentury | Mar 19, 2025
Discovery & Translation
Science Spotlight: TGFβ drives long COVID inflammation via EBV
BioCentury’s roundup of translational innovations also includes boosting T cell antitumor activity via fructose, and a new Parkinson’s risk gene
BioCentury | Mar 19, 2025
Emerging Company Profile
Trio: Introducing two new types of dual-targeting antibodies for cancer
San Francisco Bay Area biotech has two antibody platforms designed to improve on the potency and safety of bispecifics
BioCentury | Feb 27, 2025
Discovery & Translation
Science Spotlight: Clues from the clinic for neoantigen prioritization
BioCentury’s roundup of translational innovations also includes causal biology for a heart condition, and the biological foundational model Evo 2
BioCentury | Feb 15, 2025
Discovery & Translation
Science Spotlight: Using HIV to help allogeneic CAR T cells evade immune attack
BioCentury’s roundup of translational innovations also includes a human hypothalamus atlas from Novo and collaborators, and four papers with links to newcos
BioCentury | Nov 7, 2024
Discovery & Translation
Science Spotlight: Multi-epitope antivirals, metastatic transition, and more
BioCentury’s roundup of translational innovations also includes a study from Amgen and a newco spotlight
BioCentury | Oct 17, 2024
Discovery & Translation
‘Learning labs’ aim to advance learning health system
Highlander Institute, headed by former Verily executives, announces first grants
BioCentury | Oct 16, 2024
Management Tracks
KdT promotes Grayeski, Malone as firm unveils new fund
Plus: Glaub, Enright become CEO, chair at CuraSen and updates from Volastra, Essential Pharma and Transpire
BioCentury | Aug 1, 2024
Distillery Therapeutics
Activating ID3 in macrophages for anti-tumor immunity
Items per page:
1 - 10 of 724